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Epidermal growth factor stimulated cell proliferation in a primary mammary epithelial cell culture derived 
from mice at different stages of pregnancy. Moreover, the peptide hormone inhibited casein production 
induced by the synergistic actions of insulin, cortisol and prolactin. The inhibitory effect of epidermal 
growth factor was influenced by the gestational stages of the mammary gland. These effects of epidermal 
growth factor were exerted at physiological concentrations. The dual actions of epidermal growth factor 
on mammary cells implicate its participation in regulation of the growth and differentiation of the mam- 
mary gland during pregnancy. 
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1. INTRODUCTION 
Epidermal growth factor (EGF) is a polypeptide 
hormone synthesized and secreted by the salivary 
gland [l]. A number of workers have shown that 
EGF acts as a mitogen to various types of cells [ 11. 
However, the physiological function of EGF is 
unknown at present. 
The concentration of circulating EGF has been 
shown to increase during pregnancy [2] when the 
growth of the mammary gland is markedly stimu- 
lated. During this period, the mammary gland is 
unable to produce milk proteins despite the presen- 
ce of high levels of lactogenic hormones such as 
glucocorticoid and prolactin [3]. For this reason 
several factors such as progesterone [4] and cyclic 
AMP [5] have been postulated to play a negative 
regulatory role to suppress lactogenesis during 
pregnancy. However, these factors are unable to 
stimulate mammary cell proliferation, and thus the 
growth factor for mammary cell proliferation dur- 
ing pregnancy remains to be identified. 
Recently, we have developed a primary mamma- 
ry epithelial cell culture system in which the syner- 
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gistic actions of insulin, cortisol and prolactin in- 
duce milk protein synthesis 161. Using this system, 
we examined the effect of EGF on both cell proli- 
feration and milk protein synthesis in order to as- 
sess its possible role in the regulation of the growth 
and differentiation of mammary epithelium during 
pregnancy. The data demonstrate that EGF at phy- 
siological concentrations timulates mammary cell 
growth and inhibits milk protein synthesis in cultu- 
red m~mary epitheliaI cells derived from mice at 
various stages of pregnancy. These dual actions of 
EGF implicate its participation in the development 
of the mammary gland during gestation. 
2. MATERIALS AND METHODS 
C3H/HeN mice at various stages of the first 
pregnancy were obtained from the Animal Breed- 
ing Facility, National Institutes of Health. Bovine 
prolactin (NIH B5) was obtained from the Hormo- 
ne Distribution Program, NIADDK, National In- 
stitutes of Health. Crystalline porcine zinc insulin 
was a generous gift from Lilly Research Laborato- 
ries. Cortisol was purchased from Calbiochem- 
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Behring, L-3H-labeled amino acid mixture 
(1 mCi/ml), ~~e~~~f-3H]thymidine (77 Wmmol), 
and Protosol (tissue solubilizer) were purchased 
from New England Nuclear. Mouse EGF (receptor 
grade), fibroblast growth factor, multiplication sti- 
mulating activity, 2.5 S-nerve growth factor, and 
platelet-derived growth factor were purchased 
from Collaborative Research and Medium 199 
(Hanks’ salts) and fetal bovine serum were obtai- 
ned from GIBCO. Collagenase (CLS III 
120 U/mg) was purchased from Millipore Corpo- 
ration and DNase from Sigma Chemical Co. Puri- 
fied collagen was purchased from Flow 
Laboratories. 
Cell culture - Thoracic and abdominal mam- 
mary glands were removed, freed of muscle tissu- 
es, lymph nodes and connective tissue. The glands 
were finely chopped and incubated in M 199 con- 
taining 1% bovine serum albumin and 0.1% colla- 
genase at 37°C for 80 min to dissociate mammary 
epithelial cells from fat cells. The resultant cell 
suspension was passed through a double layered 
nylon mesh, and the filtrate was centrifuged at 
800 rev./min for 3 min at 25°C. After removal of 
the supernatant, the cell pellet was suspended in 
M 199 containing 10% fetal bovine serum and pla- 
ted evenly onto a collagen-coated well which was 
prepared as described [7]. Cells were incubated at 
37°C in humidified air with 5% COz. After 24 h, 
culture medium was replenished and cell culture 
was continued in M 199 containing 5% fetal bovi- 
ne serum and indicated combinations of hormones 
for 4 days with a daily medium change. 
L)NA synthesis - The extent of DNA synthesis 
was determined by allowing cells to incorporate 
13~]thymidine (0.3 ,&/ml) into trichloroacetic 
acid (TCA) insoluble materials for 24 h at the indi- 
cated times. At the end of labeling, cultured cells 
on collagen gels were harvested and gels were di- 
gested by collagenase. Cells were then treated suc- 
cessively with ice-cold 10% and 5% trichloroacetic 
acid for 15 min each, and finally washed with 95% 
ethanol. The final residues were air-dried, digested 
in 0.8 ml of Protosol and counted for radioactivi- 
ty. Over 95% of [‘Hlthymidine incorporated into 
TCA insoluble materials was sensitive to DNase 
treatment. 
Casein synthesis - Casein synthesis was deter- 
mined by allowing cells to incorporate 3H-labeled 
amino acid mixture (10 $Xml) for 24 h during 
day 4 and 5. At the end of labeling, the culture me- 
dium was harvested and centrifuged at 
3000 rev./min for 10 min to remove cell debris. 
The resultant supernatant was used for the assay of 
casein synthesis. The amount of ‘H-labeled casein 
was determined by the indirect immunoprecipitati- 
on using rabbit anti-mouse casein antiserum and 
goat anti-rabbit IgG antiserum as previously desc- 
ribed [8]. 
3. RESULTS 
The addition of EGF stimulated mammary cell 
proliferation in a dose-dependent manner during a 
4-day culture of mammary epithelial cells derived 
from mice at various stages of pregnancy (fig.1). 
The stimulatory effect of EGF was manifested at 
concentrations as low as 0.1 ng/ml and was maxi- 
mal at 10 ng/ml. The EDso value was about 
0.5-0.8 ng/ml. The maximal extent of increase in 
the cell number was about 3-fold over that in the 
absence of EGF regardless of the stage of pregnan- 
cy of mice used for culture experiments. 
The time course study indicated that the stimula- 
tory effect of EGF on DNA synthesis was apparent 
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Fig. 1. The effect of EGF concentrations on cell growth 
in cultured mammary epithelial cells from mice at dif- 
ferent gestational stages. Mammary epithelial cells deriv- 
ed from mice at 8-10 days (M), or 11-14 days 
(O--O) or 15-20 days (t-ji) of pregnancy were 
cultured for 4 days in medium containing insulin 
(5 pg/ml), cortisol (3 pM), prolactin (5 pg/ml) and the 
indicated concentrations of EGF. At the end of culture, 
the number of cells were counted in a hemocytometer. 
Each point represents the mean of closely-agreeing (SE 
< 3%) of triplicate determinations. Results are express- 
ed as viable cell count compared with controls, i.e., no 
EGF addition. 
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Fig.2. The effect of EGF on DNA synthesis in cultured 
mammary epithelial ceils from pregnant mice. Mam- 
mary epithelial cells from 11-14 days pregnant mice 
were cultured for 4 days in medium containing insulin, 
cortisol, prolactin with (o---o) or without (C--O) 
EGF (10 ng/ml). Cells were labeled with t3H]thymidine 
for 24 h prior to the indicated times. Other details are 
given in section 2 as well as in the fig.1 legend. Each 
point represents the mean k SE of 5 separate 
determinations. 
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Fig.3. The effect of EGF concentrations on casein pro- 
duction in cultured mammary epithelial cells from mice 
at different gestational stages. Mammary epithelial cells 
derived from mice at 8-10 days (ti), or 11-14 days 
(O--O), or 15-20 days (M) of pregnancy were 
cultured for 4 days in medium containing insulin 
(5 ag/ml), cortisol (3 PM), prolactin (5 pg/ml) and the 
indicated concentrations of EGF. On day 3, cells were 
labeled with 3H-labeled amino acid mixture for 24 h, 
and casein production was determined as described in 
section 2. Each point represents the mean +- SE of 8 
separate determinations. 
on day 1 and thereafter maintained at higher levels 
(fig.2). In the absence of EGF, DNA synthesis de- 
creased precipitously after day 1. 
As previously observed in organ culture of the 
mammary gland [8], the synergistic actions of insu- 
lin, cortisol and prolactin stimulated casein pro- 
duction in primary cultures of mammary epitheli- 
urn derived from mice at various stages of preg- 
nancy (fig.3). During a 4-day culture, the extent of 
increase in casein production induced by the three 
hormones was about 8-IO-fold over that in culture 
with insulin and cortisol in cultured mammary cells 
derived from mice at different stages of gestation 
(data not shown). The addition of increasing 
amounts of EGF up to 50 ng/ml to the medium 
containing the three hormones caused progressive 
inhibition of casein production in mammary cells 
derived from 15-20 day pregnant mice. The inhibi- 
tory effect of EGF was apparent at concentrations 
as low as 0.1 ng/ml and was maximal at about 
IO ng/ml, under which condition casein producti- 
on was inhibited as much as 80%. The EDso value 
was about 0.5 ng/ml. However, the inhibitory ef- 
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Fig.4. The effect of EGF on the time course of casein 
production in cultured mammary epithelial cells from 
pregnant mice. Mammary epithelial cells derived from 
15-20 days pregnant mice were cultured for 4 days in 
medium containing insulin and cortisol (M) or in- 
sulin, cortisol and prolactin (M ) or the combination 
of the three hormones plus either 0.1 ng/mi (0-Q) or 
50 ng/ml of EGF (w). Cells were labeled with ‘H- 
labeled amino acid mixture throughout the culture 
period, and casein production was determined at the in- 
dicated times as described in section 2. Each value 
represents the mean k SE of 8 separate determinations. 
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Table 1 
Effect of various growth factors on DNA synthesis and casein production in 
cultured mammary epithelial cells 
Culture condition Thymidine in- Casein production 
corporation cpm. lo6 cells-‘. 24 h-r 
cpm. dish-‘. 24 h-’ 
I+F 18980 + 1500 1680 zk 65 
I+F+P 20720 k 800 20010 + 720 
I + F + P + EGF 182370 + 6960 3830 * 208 
I + F + P + Fibroblast 
growth factor 21720 + 2530 19590 * 313 
I + F + P + Multiplication 
stimulating 
activity 19540 f 1.545 18465 + 1560 
I + F + P + Nerve growth 
factor 20020 +- 465 19696 + 1150 
I + F + P + Platelet-derived 
growth factor 19334 -t 1502 19025 + 245 
Mammary epithelial cells derived from 15-20 days pregnant mice were cultured for 4 
days in medium containing insulin (I), cortisol (F), prolactin (P) and the indicated 
growth factors. Each growth factor was used at a final concentration of 50 ng/ml, 
except platelet-derived growth factor which was used at a concentration of 1 @g/ml. 
Other details are given in the legend to fig.2 and fig.3. DNA synthesis was measured 
on day 3. Each value represents the mean + SE of 5 to 8 separate determinations 
February 1983 
feet of EGF on casein production was much less 
pronounced in cultured mammary cells derived 
from mice at less advanced stages of pregnancy. 
The results indicate that the inhibitory effect of 
EGF on casein production is influenced by the 
gestational stage of the mammary tissue. 
As shown in fig.4, the inhibitory effect of EGF 
(50 ng/ml) on casein synthesis was manifested as 
early as day 1 and continued throughout a 4-day 
culture. A lower concentration of EGF (0.1 ng/ml) 
exerted a smaller inhibition of casein production 
during this period. 
The data in table 1 indicate that the effect of 
EGF to stimulate mammary cell proliferation and 
inhibit casein production is specific in the sense 
that other growth factors such as fibroblast growth 
factor, multiplication stimulating activity, nerve 
growth factor and platelet-derived growth factor 
were ineffective in this system. 
4. DISCUSSION 
an inhibitory action on casein production in cultu- 
red mammary epithelial cells derived from preg- 
nant mice. While the mitogenic action of EGF was 
manifested equally on mammary cells derived 
from different stages of pregnancy, its inhibitory 
effect on casein production was found to be influ- 
enced by the gestational state of mammary cells. 
The ED50 value for these effects was about 
0.5 ng/ml in the case of mammary cells from 
15-20 days pregnant mice, which is in the range of 
physiological concentrations of circulating EGF 
[2]. The serum concentration of EGF increases to 
about 1.5 ng/ml during pregnancy, whereas its le- 
vel in the non-pregnant state is often below the le- 
vel of sensitivity of assay [2]. The mitogenic action 
of EGF on the mammary tissue in vitro has been 
reported by other workers [9-l 11. Based on these 
findings, it is possible that EGF participates in the 
regulation of the development of the mammary 
gland by enhancing cell growth and preventing pre- 
mature production of milk protein during 
pregnancy. 
In the present study, we have shown that EGF The present data indicate that the sensitivity of 
stimulates mammary cell proliferation and exerts mammary cells to the mitogenic action of EGF dif- 
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fers from that to the inhibitory effect of EGF on 
casein production as a function of gestational sta- 
ge, suggesting that the two effects of EGF are not 
causally related. Our recent studies of a tumor 
promotor, 12-O-tetradecanoylphorbol 13-acetate 
(TPA) in this system also indicated that the two 
events are dissociable in terms of TPA action [ 121. 
One possible explanation for these phenomena is 
that the population of mammary epithelial cells is 
heterogeneous, consisting of cells destined to proli- 
ferate and those committed to differentiate and the 
two types of cells respond differently to EGF. The 
relative abundance of these types of cells may vary 
during different stages of pregnancy as a result of 
changes in hormonal environments. Alternatively, 
the two actions of EGF are exerted on the same po- 
pulation of cells, but cellular pathway leading to 
cell proliferation and differentiation involves dif- 
ferent mechanisms that are affected differently by 
EGF. 
The mechanism by which EGF inhibits casein 
production is not known at present. Our prelimi- 
nary data indicate that EGF inhibits the accumula- 
tion of casein mRNA in this system and also redu- 
ces the binding capacity of prolactin, an essential 
lactogenic hormone. Since the receptors for EGF 
and prolactin are present on plasma cell membra- 
nes [ 13,141, it is possible that the binding of EGF 
to its receptors alters the properties of cell mem- 
branes and thus inhibits the action of prolactin. 
Studies are in progress to assess this possibility. 
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